| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/12/2009 | WO2008110624A9 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 03/12/2009 | WO2008015675A3 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 03/12/2009 | US20090069264 Toxoplasma gondii nucleic acid molecules |
| 03/12/2009 | US20090069263 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
| 03/12/2009 | US20090069261 Gene therapy for spinal cord disorders |
| 03/12/2009 | US20090069259 Treatment of neuropathic pain with zinc finger proteins |
| 03/12/2009 | US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 03/12/2009 | US20090069257 Method of achieving persistent Transgene expression |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090068745 Compositions and methods for performing reverse gene therapy |
| 03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
| 03/12/2009 | US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 03/12/2009 | US20090068636 Viral protein |
| 03/12/2009 | US20090068229 Modified surface antigen |
| 03/12/2009 | US20090068216 Modified surface antigen |
| 03/12/2009 | US20090068213 Immunogenic composition for early detection of dengue virus |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | US20090068151 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 03/12/2009 | US20090068147 Raav vector-based pro-opiomelanocortin compositions and methods of use |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068111 Methods of identifying lead compounds that modulate toxicity of neurotoxic polypeptides |
| 03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
| 03/12/2009 | US20090068094 Inhibitors of endo-exonuclease activity for treating cancer |
| 03/12/2009 | DE202008014557U1 Therapeutische Verwendung Therapeutic use |
| 03/12/2009 | CA2727971A1 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 03/12/2009 | CA2698091A1 Wnt pathway stimulation in reprogramming somatic cells |
| 03/12/2009 | CA2698011A1 Porcine adeno-associated viruses |
| 03/12/2009 | CA2697737A1 Method for promoting expression of p53, and p53 expression promoter for use in the method |
| 03/12/2009 | CA2696752A1 Complexes of rna and cationic peptides for stimulation of the innate immune system |
| 03/11/2009 | EP2034025A1 Inflammation-induced anti-inflammatory gene expression |
| 03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
| 03/11/2009 | EP2034014A1 Therapeutic agent for alzheimer's disease |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2032173A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 03/11/2009 | EP2032158A2 Adjuvant compositions |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1173567B1 Tribonectins |
| 03/11/2009 | CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 03/11/2009 | CN101384712A Meganuclease variants cleaving a DNA target sequence from a xp gene and uses thereof |
| 03/11/2009 | CN101384282A Method for production of a transformed cell |
| 03/11/2009 | CN101381742A Late promoter targeting regulation oncolytic adenovirus pCN305 vector and construction method and application thereof |
| 03/11/2009 | CN101380477A Use of CR-1 siRNA in treating myocardial hypertrophy induced by AngII |
| 03/11/2009 | CN101380473A Gold nano-bar based medicine carrier and preparation technique and use thereof |
| 03/11/2009 | CN101380310A Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof |
| 03/11/2009 | CN100467605C Adenovirus-transfected primary cells and methods of pathway mapping |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467073C Implants with a phosphazene-containing coating |
| 03/11/2009 | CA2639412A1 Prostaglandin e2 modulation and uses thereof |
| 03/10/2009 | US7501553 Non-human transgenic mammal comprising a modified MSP-1 nucleic acid |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501401 Administering oligonucleotide containing optimal nucleotide binding site for the transcription factor for therapy of disease associated with hyper-activated signal transduction pathways, particularly malignancy |
| 03/10/2009 | US7501400 Inhibition of gastric acid production and/or secretion |
| 03/10/2009 | US7501392 Method of treatment of viral hepatitis C with interferon alpha 5 |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/10/2009 | US7501114 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2197677C A method of selectively destroying neoplastic cells |
| 03/05/2009 | WO2009029688A2 Compositions of asymmetric interfering rna and uses thereof |
| 03/05/2009 | WO2009029681A2 Micrornas for inhibiting viral replication |
| 03/05/2009 | WO2009028581A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 03/05/2009 | WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | WO2009028521A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis |
| 03/05/2009 | WO2009028411A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 03/05/2009 | WO2009027978A1 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS |
| 03/05/2009 | WO2009027349A2 Treatment and prevention of neurodegenerative diseases |
| 03/05/2009 | WO2009027087A1 Means and methods for treating peripheral and cardiovascular diseases via modulation of arteriogenesis |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026705A1 Method of diagnosing and treating osteoarthritis |
| 03/05/2009 | WO2009026681A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 03/05/2009 | WO2009026653A1 Neuroplasticity assay |
| 03/05/2009 | WO2009006300A3 Production cell lines for adenoviral manufacturing |
| 03/05/2009 | WO2008141308A3 Gene expression and pain |
| 03/05/2009 | WO2008104974A3 Composition and methods for modulating cell proliferation and cell death |
| 03/05/2009 | US20090062188 Disease-Associated Protein |
| 03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
| 03/05/2009 | US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/05/2009 | US20090061521 Recombinant negative strand RNA virus expression systems and vaccines |
| 03/05/2009 | US20090061453 Methods and compositions for detecting colon cancers |
| 03/05/2009 | US20090061452 Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications |
| 03/05/2009 | US20090061008 Fiber/granule complex for treatment of the gi tract |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060896 Gene repair involving in vivo excision of targeting DNA |
| 03/05/2009 | US20090060889 Ii-RNAi involved Ii suppression in cancer immunotherapy |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | DE102007041655A1 Vermehrung von primären Zellen und deren Verwendung Multiplication of primary cells and their use |
| 03/05/2009 | CA2697517A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 03/05/2009 | CA2697513A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | CA2697512A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis |
| 03/05/2009 | CA2697070A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |